Oragenics, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 0.374 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.69M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Lakewood Ranch, Florida.
Details
| Name | Oragenics, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 3 |
| Founded | 1996 |
| Ceo | Janet Huffman |
| Country | United States |
| Exchange | NYSEAMERICAN |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US6840236094 |
| Cusip | 684023609 |
| Cik | 0001174940 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Janet Huffman | Chief Executive Officer, President, Secretary and Treasurer |
| John Spencer | Chief Financial Officer |
| Dr. James P. Kelly M.A., M.D. | Chief Medical Officer |
| Dr. William Franklin Peacock IV, F.A.C.E.P., FACC, M.D. | Chief Clinical Officer |
Contact
| Address | 9015 Town Center Parkway, Suite 143, Lakewood Ranch, Florida 34202, United States |
| Phone | 813 286 7900 |
| Website | https://www.oragenics.com |